Evershine Drug Product Private Limited, a active private limited company, was established on 05 November 2009 in Thane, Maharashtra, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U24239MH2009PTC196882. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Its leadership includes Raj Ramesh Natekar (Director), Ramesh Shankar Natekar (Director). Past directors included Uttamrao Ramchandra Londhe, Megha Dilip Ambavale, Renubala Debaraj Palai. It holds ₹1.94 Cr open charges and ₹7.20 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at W-110, M.I.D.C Phase-Ii, Dombivli (E), Thane, Maharashtra, 421203.
U24239MH2009PTC196882
196882
05 November 2009
₹2.00 M
₹1.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Evershine Drug Product Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raj Ramesh Natekar | Director | 27 Feb 2015 | Current |
| Ramesh Shankar Natekar | Director | 25 Mar 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Dec 2012 | Past |
| Pramod Abcsdd | Director | 17 Dec 2012 | Past |
| Pramod Abcsdd | Director | 21 Feb 2015 | Past |
| Pramod Abcsdd | Director | 23 Dec 2010 | Past |
| Pramod Abcsdd | Director | 03 May 2016 | Past |
| Pramod Abcsdd | Additional Director | 12 Dec 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Evershine Drug Product Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.48% decrease. The company also saw a substantial improvement in profitability, with a 14.38% increase in profit. The company's net worth Soared by an impressive increase of 36.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Evershine Drug Product had a public holding of 3.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹19,400,000.00
₹7,200,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2022 | Others | ₹1.94 Cr | Open |
| 23 Dec 2011 | State Bank Of India | ₹7.20 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Evershine Drug Product, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Evershine Drug Product, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evershine Drug Product's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Evershine Drug Product Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Evershine Drug Product Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on A charge registered on 23 Dec 2011 via Charge ID 10329069 with State Bank Of India was fully satisfied on 25 Jan 2024. was documented.
A charge with Others of Rs. 19.40 M registered on 30 Dec 2022 with Charge ID 100670998 was modified on 02 Mar 2023. was recorded as a recent event.
A charge with Others amounted to Rs. 19.40 M with Charge ID 100670998 was registered on 30 Dec 2022. was recorded as a recent event.
Progress on A charge with State Bank Of India of Rs. 7.20 M registered on 23 Dec 2011 with Charge ID 10329069 was modified on 01 Jun 2020. was documented.
The CIN of Evershine Drug Product Private Limited is U24239MH2009PTC196882.
Evershine Drug Product Private Limited is headquartered at W-110, M.I.D.C Phase-Ii, Dombivli (E), Thane, Maharashtra, 421203.
Evershine Drug Product Private Limited was incorporated on 05 November 2009.
The current directors of Evershine Drug Product Private Limited are
The primary industry of Evershine Drug Product Private Limited is Manufacturing.
Evershine Drug Product Private Limited is unlisted.
The authorized capital of Evershine Drug Product Private Limited is ₹2.00 M, and the paid-up capital is ₹1.50 M.
The compliance status of Evershine Drug Product Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX